Natural Alternatives International, Inc. Logo

Natural Alternatives International, Inc.

NAII

(1.8)
Stock Price

6,74 USD

0.48% ROA

-4.7% ROE

46.48x PER

Market Cap.

37.446.182,00 USD

63.45% DER

0% Yield

-3.22% NPM

Natural Alternatives International, Inc. Stock Analysis

Natural Alternatives International, Inc. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Natural Alternatives International, Inc. Fundamental Stock Analysis
# Analysis Rating
1 PBV

The stock's low PBV ratio (0.41x) suggests it's undervalued, making it an attractive opportunity for investors.

2 DER

The stock has a low debt to equity ratio (35%), which means it has a small amount of debt compared to the ownership it holds

3 ROE

ROE in an average range (2.84%) suggests satisfactory profitability and decent utilization of shareholders' equity.

4 ROA

The stock's ROA (1.88%) indicates that it's doing well in making money from the things it owns. This makes it a good option to invest and make consistent profits.

5 Graham Number

The Graham number analysis indicates that this company's stock price is likely undervalued, raising prospects for a favorable investment opportunity.

6 Revenue Growth

Company's revenue has stayed stagnant, showing no signs of improvement and making it a less favorable choice.

7 Net Profit Growth

The net profit of this company has shown no signs of growth over the last five years, suggesting limited profitability and making it a less attractive investment opportunity.

8 Assets Growth

Company's revenue has stayed stagnant, showing no signs of improvement and making it a less favorable choice.

9 Dividend Growth

The company's dividend growth has remained unchanged for three years, signaling a lack of positive momentum and making it a less favorable investment choice.

10 Dividend

The company has not distributed any dividends in the past three years, which may raise concerns for investors looking for regular income from their investments.

11 Buffet Intrinsic Value

The company's stock presents a potential concern as it appears overvalued (-547) by Warren Buffett's formula, indicating that its market price exceeds its estimated intrinsic value.

Natural Alternatives International, Inc. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Natural Alternatives International, Inc. Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Buy
2 MACD Buy
3 RSI Hold
4 Stoch RSI Sell

Natural Alternatives International, Inc. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Natural Alternatives International, Inc. Revenue
Year Revenue Growth
1988 7.300.000
1989 11.900.000 38.66%
1990 10.400.000 -14.42%
1991 14.500.000 28.28%
1992 19.400.000 25.26%
1993 34.300.000 43.44%
1994 37.400.000 8.29%
1995 47.600.000 21.43%
1996 49.400.000 3.64%
1997 67.900.000 27.25%
1998 57.400.000 -18.29%
1999 47.827.000 -20.02%
2000 42.158.000 -13.45%
2001 50.037.000 15.75%
2002 55.962.000 10.59%
2003 78.534.000 28.74%
2004 91.492.000 14.16%
2005 99.131.000 7.71%
2006 97.128.000 -2.06%
2007 81.755.000 -18.8%
2008 73.919.000 -10.6%
2009 65.553.000 -12.76%
2010 55.882.000 -17.31%
2011 72.822.000 23.26%
2012 62.797.000 -15.96%
2013 73.942.000 15.07%
2014 79.508.000 7%
2015 114.201.000 30.38%
2016 121.946.000 6.35%
2017 132.437.000 7.92%
2018 138.290.000 4.23%
2019 118.876.000 -16.33%
2020 178.520.000 33.41%
2021 170.966.000 -4.42%
2022 154.015.000 -11.01%
2023 135.876.000 -13.35%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Natural Alternatives International, Inc. Research and Development Expenses
Year Research and Development Expenses Growth
1988 0
1989 0 0%
1990 0 0%
1991 0 0%
1992 0 0%
1993 0 0%
1994 0 0%
1995 0 0%
1996 0 0%
1997 0 0%
1998 0 0%
1999 0 0%
2000 0 0%
2001 0 0%
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Natural Alternatives International, Inc. General and Administrative Expenses
Year General and Administrative Expenses Growth
1988 0
1989 0 0%
1990 0 0%
1991 0 0%
1992 0 0%
1993 0 0%
1994 0 0%
1995 7.200.000 100%
1996 8.600.000 16.28%
1997 9.100.000 5.49%
1998 17.300.000 47.4%
1999 11.048.000 -56.59%
2000 8.848.000 -24.86%
2001 10.684.000 17.18%
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Natural Alternatives International, Inc. EBITDA
Year EBITDA Growth
1988 1.000.000
1989 2.300.000 56.52%
1990 900.000 -155.56%
1991 1.800.000 50%
1992 2.000.000 10%
1993 4.600.000 56.52%
1994 4.600.000 0%
1995 6.200.000 25.81%
1996 2.900.000 -113.79%
1997 10.900.000 73.39%
1998 -3.300.000 430.3%
1999 -625.000 -428%
2000 1.441.000 143.37%
2001 -909.000 258.53%
2002 3.468.000 126.21%
2003 6.166.000 43.76%
2004 6.475.000 4.77%
2005 7.726.000 16.19%
2006 5.698.000 -35.59%
2007 3.666.000 -55.43%
2008 3.554.000 -3.15%
2009 6.633.000 46.42%
2010 5.566.000 -19.17%
2011 9.237.000 39.74%
2012 5.234.000 -76.48%
2013 5.613.000 6.75%
2014 6.623.000 15.25%
2015 15.767.000 57.99%
2016 12.526.000 -25.87%
2017 13.512.000 7.3%
2018 11.299.000 -19.59%
2019 2.608.000 -333.24%
2020 13.672.000 80.92%
2021 17.789.000 23.14%
2022 8.914.000 -99.56%
2023 2.536.000 -251.5%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Natural Alternatives International, Inc. Gross Profit
Year Gross Profit Growth
1988 2.600.000
1989 3.800.000 31.58%
1990 3.100.000 -22.58%
1991 4.700.000 34.04%
1992 5.700.000 17.54%
1993 10.400.000 45.19%
1994 10.900.000 4.59%
1995 13.500.000 19.26%
1996 11.700.000 -15.38%
1997 20.200.000 42.08%
1998 14.000.000 -44.29%
1999 8.506.000 -64.59%
2000 8.188.000 -3.88%
2001 10.969.000 25.35%
2002 13.181.000 16.78%
2003 18.570.000 29.02%
2004 18.397.000 -0.94%
2005 22.377.000 17.79%
2006 21.286.000 -5.13%
2007 12.912.000 -64.85%
2008 9.405.000 -37.29%
2009 10.851.000 13.33%
2010 10.629.000 -2.09%
2011 15.451.000 31.21%
2012 11.750.000 -31.5%
2013 12.738.000 7.76%
2014 14.339.000 11.17%
2015 25.258.000 43.23%
2016 26.204.000 3.61%
2017 26.320.000 0.44%
2018 23.575.000 -11.64%
2019 18.871.000 -24.93%
2020 30.442.000 38.01%
2021 30.509.000 0.22%
2022 18.158.000 -68.02%
2023 12.548.000 -44.71%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Natural Alternatives International, Inc. Net Profit
Year Net Profit Growth
1988 400.000
1989 1.100.000 63.64%
1990 300.000 -266.67%
1991 800.000 62.5%
1992 1.000.000 20%
1993 1.900.000 47.37%
1994 2.000.000 5%
1995 3.200.000 37.5%
1996 1.100.000 -190.91%
1997 5.900.000 81.36%
1998 -2.900.000 303.45%
1999 -4.472.000 35.15%
2000 -4.889.000 8.53%
2001 3.879.000 226.04%
2002 1.105.000 -251.04%
2003 3.000.000 63.17%
2004 2.199.000 -36.43%
2005 2.670.000 17.64%
2006 -5.285.000 150.52%
2007 -371.000 -1324.53%
2008 -4.080.000 90.91%
2009 4.127.000 198.86%
2010 5.086.000 18.86%
2011 4.158.000 -22.32%
2012 1.570.000 -164.84%
2013 1.994.000 21.26%
2014 3.346.000 40.41%
2015 9.546.000 64.95%
2016 7.235.000 -31.94%
2017 5.051.000 -43.24%
2018 6.541.000 22.78%
2019 -1.645.000 497.63%
2020 10.768.000 115.28%
2021 10.712.000 -0.52%
2022 2.522.000 -324.74%
2023 -2.780.000 190.72%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Natural Alternatives International, Inc. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
1988 0
1989 0 0%
1990 0 0%
1991 0 0%
1992 0 0%
1993 0 0%
1994 0 0%
1995 1 0%
1996 0 0%
1997 1 100%
1998 0 0%
1999 -1 0%
2000 -1 0%
2001 1 0%
2002 0 0%
2003 1 0%
2004 0 0%
2005 0 0%
2006 -1 0%
2007 0 0%
2008 -1 0%
2009 1 0%
2010 1 0%
2011 1 0%
2012 0 0%
2013 0 0%
2014 1 0%
2015 1 100%
2016 1 0%
2017 1 0%
2018 1 0%
2019 0 0%
2020 2 100%
2021 2 0%
2022 0 0%
2023 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Natural Alternatives International, Inc. Free Cashflow
Year Free Cashflow Growth
1990 -700.000
1991 -100.000 -600%
1992 100.000 200%
1993 -3.500.000 102.86%
1994 1.700.000 305.88%
1995 -1.500.000 213.33%
1996 1.600.000 193.75%
1997 -300.000 633.33%
1998 -2.600.000 88.46%
1999 -6.810.000 61.82%
2000 3.424.000 298.89%
2001 3.727.000 8.13%
2002 2.318.000 -60.79%
2003 -38.000 6200%
2004 -5.188.000 99.27%
2005 -6.111.000 15.1%
2006 12.329.000 149.57%
2007 1.316.000 -836.85%
2008 357.000 -268.63%
2009 4.555.000 92.16%
2010 7.370.000 38.2%
2011 -529.000 1493.19%
2012 2.849.000 118.57%
2013 2.668.000 -6.78%
2014 970.000 -175.05%
2015 -1.156.000 183.91%
2016 8.783.000 113.16%
2017 -2.248.000 490.7%
2018 1.237.000 281.73%
2019 -850.000 245.53%
2020 15.699.000 105.41%
2021 -14.622.000 207.37%
2022 -6.505.000 -124.78%
2023 3.218.000 302.14%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Natural Alternatives International, Inc. Operating Cashflow
Year Operating Cashflow Growth
1990 400.000
1991 400.000 0%
1992 1.800.000 77.78%
1993 -1.500.000 220%
1994 3.500.000 142.86%
1995 1.100.000 -218.18%
1996 3.800.000 71.05%
1997 3.200.000 -18.75%
1998 3.100.000 -3.23%
1999 -1.649.000 287.99%
2000 4.384.000 137.61%
2001 4.803.000 8.72%
2002 3.295.000 -45.77%
2003 3.284.000 -0.33%
2004 2.518.000 -30.42%
2005 -3.816.000 165.99%
2006 15.058.000 125.34%
2007 2.688.000 -460.19%
2008 4.887.000 45%
2009 7.088.000 31.05%
2010 9.087.000 22%
2011 1.730.000 -425.26%
2012 4.470.000 61.3%
2013 5.347.000 16.4%
2014 2.678.000 -99.66%
2015 9.285.000 71.16%
2016 14.137.000 34.32%
2017 1.833.000 -671.25%
2018 6.564.000 72.07%
2019 3.691.000 -77.84%
2020 20.806.000 82.26%
2021 11.866.000 -75.34%
2022 7.019.000 -69.06%
2023 4.496.000 -56.12%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Natural Alternatives International, Inc. Capital Expenditure
Year Capital Expenditure Growth
1990 1.100.000
1991 500.000 -120%
1992 1.700.000 70.59%
1993 2.000.000 15%
1994 1.800.000 -11.11%
1995 2.600.000 30.77%
1996 2.200.000 -18.18%
1997 3.500.000 37.14%
1998 5.700.000 38.6%
1999 5.161.000 -10.44%
2000 960.000 -437.6%
2001 1.076.000 10.78%
2002 977.000 -10.13%
2003 3.322.000 70.59%
2004 7.706.000 56.89%
2005 2.295.000 -235.77%
2006 2.729.000 15.9%
2007 1.372.000 -98.91%
2008 4.530.000 69.71%
2009 2.533.000 -78.84%
2010 1.717.000 -47.52%
2011 2.259.000 23.99%
2012 1.621.000 -39.36%
2013 2.679.000 39.49%
2014 1.708.000 -56.85%
2015 10.441.000 83.64%
2016 5.354.000 -95.01%
2017 4.081.000 -31.19%
2018 5.327.000 23.39%
2019 4.541.000 -17.31%
2020 5.107.000 11.08%
2021 26.488.000 80.72%
2022 13.524.000 -95.86%
2023 1.278.000 -958.22%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Natural Alternatives International, Inc. Equity
Year Equity Growth
1988 1.700.000
1989 2.800.000 39.29%
1990 3.000.000 6.67%
1991 6.000.000 50%
1992 6.900.000 13.04%
1993 11.200.000 38.39%
1994 13.300.000 15.79%
1995 17.200.000 22.67%
1996 18.700.000 8.02%
1997 27.700.000 32.49%
1998 25.100.000 -10.36%
1999 20.486.000 -22.52%
2000 15.604.000 -31.29%
2001 19.608.000 20.42%
2002 20.777.000 5.63%
2003 24.128.000 13.89%
2004 26.917.000 10.36%
2005 33.291.000 19.15%
2006 30.022.000 -10.89%
2007 30.002.000 -0.07%
2008 26.032.000 -15.25%
2009 30.610.000 14.96%
2010 35.478.000 13.72%
2011 39.868.000 11.01%
2012 40.339.000 1.17%
2013 42.438.000 4.95%
2014 43.860.000 3.24%
2015 53.726.000 18.36%
2016 61.148.000 12.14%
2017 68.248.000 10.4%
2018 76.084.000 10.3%
2019 71.375.000 -6.6%
2020 80.083.000 10.87%
2021 88.520.000 9.53%
2022 88.772.000 0.28%
2023 88.815.000 0.05%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Natural Alternatives International, Inc. Assets
Year Assets Growth
1988 3.100.000
1989 5.300.000 41.51%
1990 5.800.000 8.62%
1991 8.000.000 27.5%
1992 10.500.000 23.81%
1993 17.500.000 40%
1994 21.200.000 17.45%
1995 23.600.000 10.17%
1996 27.700.000 14.8%
1997 43.000.000 35.58%
1998 38.600.000 -11.4%
1999 34.875.000 -10.68%
2000 25.068.000 -39.12%
2001 27.510.000 8.88%
2002 30.724.000 10.46%
2003 42.468.000 27.65%
2004 44.138.000 3.78%
2005 62.453.000 29.33%
2006 47.380.000 -31.81%
2007 47.010.000 -0.79%
2008 36.439.000 -29.01%
2009 36.148.000 -0.81%
2010 41.144.000 12.14%
2011 47.197.000 12.82%
2012 46.640.000 -1.19%
2013 52.258.000 10.75%
2014 53.816.000 2.9%
2015 74.175.000 27.45%
2016 72.611.000 -2.15%
2017 85.207.000 14.78%
2018 93.490.000 8.86%
2019 120.203.000 22.22%
2020 120.281.000 0.06%
2021 146.003.000 17.62%
2022 134.152.000 -8.83%
2023 160.252.000 16.29%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Natural Alternatives International, Inc. Liabilities
Year Liabilities Growth
1988 1.400.000
1989 2.500.000 44%
1990 2.800.000 10.71%
1991 2.000.000 -40%
1992 3.600.000 44.44%
1993 6.300.000 42.86%
1994 7.900.000 20.25%
1995 6.400.000 -23.44%
1996 9.000.000 28.89%
1997 15.300.000 41.18%
1998 13.500.000 -13.33%
1999 14.389.000 6.18%
2000 9.464.000 -52.04%
2001 7.902.000 -19.77%
2002 9.947.000 20.56%
2003 18.340.000 45.76%
2004 17.221.000 -6.5%
2005 29.162.000 40.95%
2006 17.358.000 -68%
2007 17.008.000 -2.06%
2008 10.407.000 -63.43%
2009 5.538.000 -87.92%
2010 5.666.000 2.26%
2011 7.329.000 22.69%
2012 6.301.000 -16.31%
2013 9.820.000 35.84%
2014 9.956.000 1.37%
2015 20.449.000 51.31%
2016 11.463.000 -78.39%
2017 16.959.000 32.41%
2018 17.406.000 2.57%
2019 48.828.000 64.35%
2020 40.198.000 -21.47%
2021 57.483.000 30.07%
2022 45.380.000 -26.67%
2023 71.437.000 36.48%

Natural Alternatives International, Inc. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
24.76
Net Income per Share
0.13
Price to Earning Ratio
46.48x
Price To Sales Ratio
0.26x
POCF Ratio
2.24
PFCF Ratio
4.14
Price to Book Ratio
0.41
EV to Sales
0.53
EV Over EBITDA
10.93
EV to Operating CashFlow
4.79
EV to FreeCashFlow
8.52
Earnings Yield
0.02
FreeCashFlow Yield
0.24
Market Cap
0,04 Bil.
Enterprise Value
0,08 Bil.
Graham Number
6.72
Graham NetNet
-6.06

Income Statement Metrics

Net Income per Share
0.13
Income Quality
20.77
ROE
0.01
Return On Assets
-0.03
Return On Capital Employed
-0.02
Net Income per EBT
0.86
EBT Per Ebit
1.41
Ebit per Revenue
-0.03
Effective Tax Rate
0.14

Margins

Sales, General, & Administrative to Revenue
0
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0.01
Gross Profit Margin
0.08
Operating Profit Margin
-0.03
Pretax Profit Margin
-0.04
Net Profit Margin
-0.03

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
2.75
Free CashFlow per Share
1.55
Capex to Operating CashFlow
-0.44
Capex to Revenue
-0.05
Capex to Depreciation
-1.58
Return on Invested Capital
0.01
Return on Tangible Assets
0
Days Sales Outstanding
25.42
Days Payables Outstanding
21.55
Days of Inventory on Hand
65.97
Receivables Turnover
14.36
Payables Turnover
16.93
Inventory Turnover
5.53
Capex per Share
-1.2

Balance Sheet

Cash per Share
2,86
Book Value per Share
15,18
Tangible Book Value per Share
15.18
Shareholders Equity per Share
15.18
Interest Debt per Share
9.71
Debt to Equity
0.63
Debt to Assets
0.35
Net Debt to EBITDA
5.62
Current Ratio
3.74
Tangible Asset Value
0,09 Bil.
Net Current Asset Value
-0,01 Bil.
Invested Capital
0.63
Working Capital
0,04 Bil.
Intangibles to Total Assets
0
Average Receivables
0,01 Bil.
Average Payables
0,01 Bil.
Average Inventory
26499000
Debt to Market Cap
1.5

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Natural Alternatives International, Inc. Dividends
Year Dividends Growth

Natural Alternatives International, Inc. Profile

About Natural Alternatives International, Inc.

Natural Alternatives International, Inc. engages in formulating, manufacturing, and marketing nutritional supplements in the United States, Europe, Asia, and internationally. The company operates in two segments, Private-Label Contract Manufacturing, and Patent and Trademark Licensing. It offers private-label contract manufacturing services to companies that market and distribute vitamins, minerals, herbal, and other nutritional supplements, as well as other health care products. The company also provides strategic partnering services, such as customized product formulation, clinical studies, manufacturing, marketing support, international regulatory and label law compliance, international product registration, packaging in multiple formats and labeling design, scientific research, proprietary ingredients, customer-specific nutritional product formulation, product testing and evaluation, packaging and delivery system design, and regulatory review. In addition, it sells beta-alanine ingredient under the CarnoSyn and SR CarnoSyn names. The company manufactures products in various forms, including capsules, tablets, chewable wafers, and powders. Its private-label contract manufacturing customers include companies that market nutritional supplements through direct sales marketing channels, direct to consumer e-commerce channels, and retail stores. Natural Alternatives International, Inc. was founded in 1980 and is headquartered in Carlsbad, California.

CEO
Mr. Mark A. LeDoux J.D.
Employee
317
Address
1535 Faraday Avenue
Carlsbad, 92008

Natural Alternatives International, Inc. Executives & BODs

Natural Alternatives International, Inc. Executives & BODs
# Name Age
1 Mr. Mark A. LeDoux J.D.
Chairman of the Board & Chief Executive Officer
70
2 Mr. Kenneth E. Wolf
President, Chief Operating Officer & Secretary
70
3 Mr. Michael E. Fortin
Chief Financial Officer
70
4 Mr. Shane Conti
Vice President of Global Sales
70

Natural Alternatives International, Inc. Competitors